Search
for
Sort by
Research 451–480 of 1000+
- MYB83 plays an important negative role in ethylene‐mediated root hair growth and involves in plant tolerance three major nutrient deficiencies
- Stability Study of Finasteride: Stability-Indicating LC Method, In Silico and LC–ESI-MS Analysis of Major Degradation Product, and an In Vitro Biological Safety Study
- En pacientes jóvenes, el uso de finasteride podría asociarse con mayor riesgo de ansiedad, depresión y eventos adversos relacionados con el suicidio
- A Keratinocyte-specific Epoxygenase, CYP2B12, Metabolizes Arachidonic Acid with Unusual Selectivity, Producing a Single Major Epoxyeicosatrienoic Acid
- Non-clinical safety evaluation and risk assessment to human of aleglitazar, a dual PPAR α/γ agonist, and its major human metabolite
- Ethnobotanical study of endemic and non-endemic medicinal plants used by indigenous people in environs of Gullele botanical garden Addis Ababa, central Ethiopia: A major focus on Asteraceae family
- Neurosteroidogenesis Is Required for the Physiological Response to Stress: Role of Neurosteroid-Sensitive GABA<sub>A</sub>Receptors
- Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients
- Does collapse of immune privilege in the hair-follicle bulge play a role in the pathogenesis of primary cicatricial alopecia?
- Effects of cyclosporine A on clinical and histologic abnormalities in dogs with sebaceous adenitis
- Integrated safety analysis of baricitinib in adults with severe alopecia areata from two randomized clinical trials
- The role of natural killer cells in autoimmune blistering diseases
- The associated burden of mental health conditions in alopecia areata: a population‐based study in UK primary care*
- Baricitinib Safety for Events of Special Interest in Populations at Risk: Analysis from Randomised Trial Data Across Rheumatologic and Dermatologic Indications
- Epidermal growth factor receptor/mitogen-activated kinase inhibitor treatment induces a distinct inflammatory hair follicle response that includes collapse of immune privilege
- Case of alopecia induced by sorafenib, possible mechanism similar to alopecia areata
- 516 Possible role of ILC1 in the pathogenesis of alopecia areata (AA)
- Updated Integrated Safety Analysis of Ritlecitinib Up to ~5 Years in Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Prevalence of autoimmune and inflammatory diseases and mental health conditions among an alopecia areata cohort from a US administrative claims database
- Can gut flora changes be new biomarkers for depression?
- When hair dig into the brain, JAKi , may help!
- Psychiatric Comorbidities in Pseudofolliculitis Barbae: A Cross-Sectional Study of the All of Us Database
- Association of Janus kinase inhibitors with reduced depression in alopecia areata
- Updated Integrated Safety Analysis of Ritlecitinib Over 72 Months In Patients With Alopecia Areata From the ALLEGRO Clinical Trial Program
- Causal Link of Distinct Mental Disorders with Androgenetic Alopecia and Alopecia Areata: A Bidirectional Two-Sample Mendelian Randomization Study
- Exploring the hair follicle immune privilege state in nonsegmental vitiligo
- Expression of the Wnt signaling pathway and hair follicle development in Rex rabbits of different ages
- Hair Loss as a Side Effect of Quetiapine: A Clinical Case Report
- Integrated Safety Analysis of Ritlecitinib, an Oral JAK3/TEC Family Kinase Inhibitor, for the Treatment of Alopecia Areata from the ALLEGRO Clinical Trial Program
- Efficacy and safety of baricitinib in patients with alopecia areata: evidence to date